Non-clinical safety assessment of NES100 to support analgesia indication. POP: 09/18/2020 to 04/17/2021.
Ended Awarded Last action
- Contract number
- 75N95020F00002
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,734,236
Award facts
- Opportunity
-
- CRO Support for NCATS In Vitro and In Vivo Toxicology Studies Pre-Solicitation · N01TR17200220 · Posted Apr 7, 2020
- Contract value 100% obligated
- $4,734,236.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $261,695 | |
| Supplemental Agreement for work within scope | $357,013 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $286,120 | |
| Supplemental Agreement for work within scope | $518,647 | |
| Supplemental Agreement for work within scope | $1,113,524 | |
| Exercise an Option | $1,410,992 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $23,257 | |
| Supplemental Agreement for work within scope | $202,454 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $560,534 |
Show all 13
About this award
This is a $4,734,236.00 delivery order under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" IDIQ contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The award is for non-clinical safety assessment of NES100 to support an analgesia indication, with a period of performance from September 18, 2020 to April 17, 2021. The prime contractor is Battelle Memorial Institute, a nonprofit research and development organization. Battelle has subcontracted portions of the work to Inotiv, Inc., a for-profit contract research organization, to conduct bone marrow micronucleus analysis, toxicology studies, and other services. No set-aside was used for this award.
Quick answers
Who was awarded contract 75N95020F00002?
75N95020F00002 was awarded to Battelle Memorial Institute by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2020.
How much is contract 75N95020F00002 worth?
The government has obligated $4,734,236 on 75N95020F00002.
Which agency awarded contract 75N95020F00002?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020F00002, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95020F00002 an order under another contract?
Yes. 75N95020F00002 is a delivery order under HHSN271201700015I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.
Was contract 75N95020F00002 competed?
The extent of competition for 75N95020F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award